Kalizhejeong 50 Units (Calidino-genase)

Adult dose

Administer 30~150 I.U. per day orally in 3 divided doses. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients with bleeding, such as those who have recently experienced a cerebral hemorrhage. This medication contains lactose, so it should not be administered to patients with a genetic disease that affects lactose digestion. Allergic reactions such as skin rash or itching may occur when using this medication, and if such symptoms appear, discontinuation of use should be immediate. Symptoms of rapid heartbeat may occur rarely, so caution is advised in this regard. Gastrointestinal symptoms such as discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur. Occasionally, symptoms like a feeling of fever, headache, a heavy feeling in the head, drowsiness, or fatigue may also be experienced. Particularly for older individuals, as physical function may be diminished, careful management, such as reducing the dosage, should be taken when using this medication.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage ensures the safety of the medication's effectiveness.

Appearance

White round enteric-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle